New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy

Details for Australian Patent Application No. 2005202560 (hide)

Owner Biogen Idec Inc.

Inventors Rastetter, William; White, Christine

Agent Davies Collison Cave

Pub. Number AU-B-2005202560

Parent 780222

Filing date 10 June 2005

Wipo publication date 7 July 2005

Acceptance publication date 31 January 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

30 June 2005 Complete Application Filed

7 July 2005 Application Open to Public Inspection

  Published as AU-B-2005202560

31 January 2008 Application Accepted

  Published as AU-B-2005202560

29 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202561-Apparatus for preparing curd and for feeding the prepared curd to a curd processing apparatus

2005202559-Power source for electric arc welding